Blog
RSS FeedPosted by Michael Wonder on 12 Mar 2023
Medicare Part D coverage of anti-obesity medications — challenges and uncertainty ahead
11 March 2023 - Obesity is highly prevalent in the United States — affecting more than 41% of adults, including a ...
Posted by Michael Wonder on 08 Mar 2023
Biden calls for tax on the wealthy to extend Medicare funding
8 March 2023 - President Joe Biden this week called for higher taxes on wealthy Americans to extend Medicare funding as ...
Posted by Michael Wonder on 28 Feb 2023
Drugs likely subject to Medicare negotiation (2026-2028)
28 February 2023 - In 2026-2028, we estimate that Medicare will negotiate prices for 38 Medicare Part D drugs and 2 ...
Posted by Michael Wonder on 23 Feb 2023
US Medicare says no change to Alzheimer's drug restrictions
23 February 2023 - The US Government health plan for people over the age of 65 on Wednesday said it ...
Posted by Michael Wonder on 20 Feb 2023
Medicare annual statistics – rolling 12 months (July 2009 to December 2022)
20 February 2023 - This document presents rolling 12 month Medicare statistics by three variables ...
Posted by Michael Wonder on 20 Feb 2023
Senators call on Medicare to offer broad coverage of Alzheimer’s treatments as public pressure grows
17 February 2023 - A group of 20 senators called on Medicare to take action now to offer seniors immediate access ...
Posted by Michael Wonder on 20 Feb 2023
US to select 10 costliest drugs for Medicare pricing negotiation
18 February 2023 - The US Government will select the 10 costliest prescription medicines to Medicare for negotiating prices with ...
Posted by Michael Wonder on 17 Feb 2023
Maker of promising Alzheimer’s drug Leqembi expects full FDA approval this summer, expanded Medicare coverage
17 February 2023 - Eisai anticipates about 100,000 patients diagnosed will be eligible for the drug by year three of its ...
Posted by Michael Wonder on 10 Feb 2023
HHS releases initial guidance for Medicare prescription drug inflation rebate program
9 February 2023 - Under President Biden’s prescription drug law, drug companies will pay rebates to the federal government for ...
Posted by Michael Wonder on 07 Feb 2023
Miracle’ cystic fibrosis drug kept out of reach in developing countries
7 February 2023 - Vertex Pharmaceuticals is not making its drug, Trikafta, available in poorer countries, where thousands of diagnosed patients ...
Posted by Michael Wonder on 05 Feb 2023
Release of the Strengthening Medicare Taskforce Report
3 February 2023 - The Strengthening Medicare Taskforce Report is now available. ...
Posted by Michael Wonder on 05 Feb 2023
Smoothing Medicare Part D out of pocket costs under the Inflation Reduction Act
3 February 2023 - The Inflation Reduction Act of 2022 marks the first major overhaul of the Medicare Part D prescription ...
Posted by Michael Wonder on 03 Feb 2023
Strengthening Medicare for the future
3 February 2023 - The Albanese Government has released the Strengthening Medicare Taskforce report. ...
Posted by Michael Wonder on 02 Feb 2023
‘Enough sickness’ to share GP load among pharmacists, nurses
2 February 2023 - Pharmacy Guild of Australia president Trent Twomey says there is enough “demand and sickness” to allow ...
Posted by Michael Wonder on 31 Jan 2023
Medicare drug price negotiation in the United States: implications and unanswered questions
8 December 2022 - The United States is a relatively free pricing market for pharmaceutical manufacturers to set list prices at ...